分子育種市場－全球產業規模、佔有率、趨勢、機會、預測：按標記、應用、製程、地區和競爭對手分類，2021-2031年

全球分子育種市場預計將從 2025 年的 77.9 億美元成長到 2031 年的 123.7 億美元，年複合成長率為 8.01%。

該領域專注於利用分子生物學技術，特別是DNA標記，在不進行基因工程的情況下，鑑定具有特定遺傳優勢（例如抗病性或增產）的動植物。由於無需等待表現型發育即可鑑定基因，因此該方法顯著加快了育種進程。市場的主要促進因素是全球對高品質食品供應日益成長的需求以及對耐氣候變遷作物的迫切需求。這並非暫時的市場趨勢，而是農業永續性的根本性和長期性要求。

然而，各國複雜且分散的監管體系阻礙了這一市場擴張。育種技術政策的差異造成了巨大的合規障礙，可能延緩改良品種的市場准入。國際種子聯盟2024年的數據凸顯了這一問題，約75%的種子產業專家警告稱，不一致或不科學的監管規定威脅著該產業保障全球糧食安全的能力。此類監管方面的不確定性會阻礙遺傳物質的國際交流，為研究資金籌措帶來挑戰，並減緩分子育種技術進步的傳播。

市場促進因素

CRISPR-Cas9 和先進基因編輯工具的引入正在改變全球分子育種市場，使無需引入外源 DNA 即可進行精準的基因修飾成為可能。這項技術進步使育種者能夠比傳統方法更快地培育出高產量、耐候性強的作物，有效省去了以往漫長的回交階段。法規環境對這些技術的接受度日益提高，基因編輯作物與傳統育種作物的分類也越來越趨於一致。這降低了合規成本和進入門檻。根據 Euroseeds 統計，截至 2024 年底，全球已有約 300 項監管決定批准將「新基因組技術 (NGT) 植物」核准傳統分類，預計到 2025 年 1 月，相關政策協調將取得進展，從而促進國際貿易和推廣。

同時，公共和私人部門對農業基因組研究與開發的投資不斷增加，加速了獨特育種資源和先進基因分型系統的創建。領先的農業公司正大力投資加強其分子育種能力，以保護智慧財產權並獲得競爭優勢。例如，科迪華農業科技公司（Corteva AgriScience）在2025年初報告稱，其2024會計年度的年度研發支出達到14.02億美元，凸顯了支持這項創新的資金規模。這些投資也正在產生商業性效益；先正達集團（Syngenta Group）在2025年3月宣布，其種子部門的全年銷售額將達到48億美元，證實了全球對先進種子產品的強勁需求。

市場挑戰

全球分子育種市場的成長受到國際各地區複雜且分散的法律規範的嚴重阻礙。這種監管缺乏協調性為育種公司帶來了巨大的不確定性，因為在一個國家利用分子育種技術開發的品種可能在出口市場遭到核准，或者需要進行昂貴且反覆的安全評估。這種不一致性迫使企業在錯綜複雜的合規要求中摸索前行，直接增加了研發成本，並延緩了改良動植物品種的市場推廣。因此，與這些監管障礙相關的高額財務風險正在阻礙對新育種計劃的投資，尤其是在那些難以承擔高昂合規成本的小眾作物領域。

近期行業統計數據凸顯了這一障礙的嚴重性。根據國際種子聯盟（ISF）2024年的一項調查，約33%的全球種子產業專業人士認為，建立可預測的、以科學為基礎的監管體係是釋放創新潛力的關鍵。這一數字表明，現有的監管壁壘構成了重大瓶頸，有效地阻礙了分子育種解決方案的規模化應用，並限制了商業性獲取優良遺傳性狀的途徑。

市場趨勢

人工智慧驅動的預測育種模型正迅速成為全球分子育種市場的變革力量，重塑著遺傳改良的實現方式。與依賴表現型觀察的傳統選擇技術不同，這些先進的計算系統能夠處理海量基因組資料集，並高精度地預測性狀結果。這最佳化了親代選擇，縮短了育種週期。這項技術進步正為採用精準育種的主要企業帶來實質的商業性成果。例如，拜耳公司在2025年11月公佈，其玉米種子及性狀部門2025年第三季的銷售額成長了22.4%。這一強勁的業績歸功於種植面積的擴大以及透過這些先進流程開發的高性能遺傳資源的應用。

同時，市場正見證著分子技術應用從傳統作物科學向水產養殖和畜牧業的顯著擴張。這項轉變的特點是基因組選擇工具的廣泛應用，旨在提高動物群體的抗病能力、飼料轉換率和繁殖能力，這對於滿足全球日益成長的蛋白質需求至關重要。領先的動物用藥品公司近期的財務表現也印證了這一趨勢的商業性可行性。根據碩騰公司（Zoetis）的數據顯示，截至2025年11月，該公司2025年第三季畜牧業的有機營業收入達7.25億美元，較去年同期成長10%。這表明，企業越來越依賴先進的遺傳學和健康解決方案來提高生產力。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球分子育種市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 標記特異性方法（簡單重複序列、單核苷酸多態性、表現序列標籤等）
  • 按用途（植物、牲畜）
  • 基於過程的選擇（標記輔助選擇、QTL定位、標記輔助回交）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美分子育種市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲分子育種市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區分子育種市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲分子育種市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲分子育種市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球分子育種市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Eurofins Scientific SE
• GC Group
• Illumina Inc.
• SGS SA
• Thermo-Fisher Scientific Inc.
• Intertek Group plc
• LemnaTec GmbH
• Charles River Laboratories International Inc.
• Bayer AG
• Slipstream Solutions

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Molecular Breeding Market is projected to expand from USD 7.79 Billion in 2025 to USD 12.37 Billion by 2031, reflecting a compound annual growth rate of 8.01%. This sector focuses on utilizing molecular biology techniques, particularly DNA markers, to identify plants or animals possessing specific genetic advantages like disease resistance or enhanced yield without necessarily using genetic modification. By enabling the identification of genes without waiting for phenotypic expression, this approach significantly hastens the breeding timeline. The market is primarily propelled by the intensifying global need for high-quality food supplies and the critical demand for crops capable of withstanding climate instability, which represents a fundamental, long-term requirement for agricultural sustainability rather than a fleeting market trend.

However, the expansion of this market is obstructed by complicated and disjointed regulatory systems across various nations. Divergent policies concerning breeding technologies create significant compliance obstacles that can postpone the market entry of enhanced varieties. Data from the International Seed Federation in 2024 highlights this issue, noting that nearly 75% of seed industry experts warned that inconsistent or unscientific regulations jeopardize the sector's ability to ensure global food security. Such regulatory unpredictability hinders the international exchange of genetic materials and fosters a challenging climate for research funding, potentially retarding the uptake of molecular breeding advancements.

Market Driver

The incorporation of CRISPR-Cas9 and sophisticated gene-editing instruments is transforming the Global Molecular Breeding Market by facilitating exact genetic adjustments that do not require foreign DNA integration. This technological evolution empowers breeders to generate high-yielding, climate-resilient crops much faster than traditional techniques, effectively skipping the prolonged backcrossing stages previously needed. Regulatory environments are increasingly accepting these advancements, often classifying gene-edited crops similarly to conventionally bred ones, which reduces compliance costs and barriers to entry. According to Euroseeds, by January 2025, nearly 300 regulatory rulings had affirmed the conventional classification of New Genomic Technique (NGT) plants worldwide by the end of 2024, indicating a policy harmonization that promotes international trade and adoption.

Simultaneously, increased public and private investment in agrogenomic research and development is accelerating the creation of proprietary germplasm and cutting-edge genotyping systems. Major agricultural entities are dedicating significant funds to enhance their molecular breeding capabilities to protect intellectual property and gain a competitive edge. For example, Corteva Agriscience reported in early 2025 that its annual R&D expenditures for 2024 reached $1.402 billion, highlighting the magnitude of financial dedication fueling this innovation. These investments are yielding commercial results, as demonstrated by Syngenta Group in March 2025, when its Seeds unit reported full-year sales of $4.8 billion, confirming strong global demand for advanced seed products.

Market Challenge

The growth of the Global Molecular Breeding Market is severely hindered by intricate and fragmented regulatory structures across various international regions. This lack of regulatory harmony generates considerable uncertainty for breeding firms, as varieties created with molecular tools in one nation might face denial or demand expensive, repetitive safety evaluations in export markets. Such inconsistency compels organizations to maneuver through a complex maze of compliance mandates, directly inflating research and development expenses while delaying the launch of improved animal and crop varieties. Consequently, the elevated financial risks linked to these regulatory obstacles deter investment in novel breeding initiatives, especially for niche crops that cannot sustain high compliance costs.

Recent industry statistics illustrate the gravity of this impediment. As per the International Seed Federation in 2024, roughly 33% of global seed sector experts pinpointed the establishment of predictable, science-based regulations as the most essential requirement for unleashing innovation. This figure emphasizes that existing regulatory obstructions serve as a major bottleneck, effectively pausing the industry's capacity to expand molecular breeding solutions and restricting the commercial accessibility of superior genetic traits.

Market Trends

The implementation of AI-powered predictive breeding models is fast becoming a game-changing trend in the Global Molecular Breeding Market, reshaping how genetic improvements are achieved. In contrast to conventional selection techniques dependent on phenotypic observation, these sophisticated computational systems process immense genomic datasets to forecast trait outcomes with great precision, thereby refining parental selection and condensing development timelines. This technological evolution is driving tangible commercial results for leading agriscience companies that have adopted precision breeding. For instance, Bayer reported in November 2025 that sales in its Corn Seed & Traits division rose by 22.4% during the third quarter of 2025, a strong performance attributed to expanded planting areas and the adoption of high-performance germplasm created via these advanced pipelines.

Concurrently, the market is observing a notable broadening of molecular applications into aquaculture and livestock, extending beyond its traditional focus on crop science. This shift is marked by the increasing utilization of genomic selection instruments to improve disease resistance, feed efficiency, and reproductive qualities in animal populations, which is vital for satisfying the rising global protein demand. The commercial feasibility of this trend is highlighted by recent financial outcomes from major animal health firms. According to Zoetis, in November 2025, the company realized a 10% increase in organic operational revenue for livestock in the third quarter of 2025, totaling $725 million, demonstrating the growing dependence of swine and cattle producers on advanced genetic and health solutions to optimize productivity.

Key Market Players

• Eurofins Scientific SE
• GC Group
• Illumina Inc.
• SGS SA
• Thermo-Fisher Scientific Inc.
• Intertek Group plc
• LemnaTec GmbH
• Charles River Laboratories International Inc.
• Bayer AG
• Slipstream Solutions

Report Scope

In this report, the Global Molecular Breeding Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Molecular Breeding Market, By Marker

• Simple Sequence Repeat
• Single Nucleotide Polymorphism
• Expressed Sequence Tags
• Others

Molecular Breeding Market, By Application

• Plant
• Livestock

Molecular Breeding Market, By Process

• Marker Assisted Selection
• QTL Mapping
• Marker assisted back crossing

Molecular Breeding Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Molecular Breeding Market.

Available Customizations:

Global Molecular Breeding Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Molecular Breeding Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Marker (Simple Sequence Repeat, Single Nucleotide Polymorphism, Expressed Sequence Tags, Others)
  • 5.2.2. By Application (Plant, Livestock)
  • 5.2.3. By Process (Marker Assisted Selection, QTL Mapping, Marker assisted back crossing)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Molecular Breeding Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Marker
  • 6.2.2. By Application
  • 6.2.3. By Process
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Molecular Breeding Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Marker
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Process
  • 6.3.2. Canada Molecular Breeding Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Marker
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Process
  • 6.3.3. Mexico Molecular Breeding Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Marker
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Process

7. Europe Molecular Breeding Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Marker
  • 7.2.2. By Application
  • 7.2.3. By Process
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Molecular Breeding Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Marker
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Process
  • 7.3.2. France Molecular Breeding Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Marker
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Process
  • 7.3.3. United Kingdom Molecular Breeding Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Marker
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Process
  • 7.3.4. Italy Molecular Breeding Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Marker
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Process
  • 7.3.5. Spain Molecular Breeding Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Marker
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Process

8. Asia Pacific Molecular Breeding Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Marker
  • 8.2.2. By Application
  • 8.2.3. By Process
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Molecular Breeding Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Marker
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Process
  • 8.3.2. India Molecular Breeding Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Marker
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Process
  • 8.3.3. Japan Molecular Breeding Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Marker
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Process
  • 8.3.4. South Korea Molecular Breeding Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Marker
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Process
  • 8.3.5. Australia Molecular Breeding Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Marker
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Process

9. Middle East & Africa Molecular Breeding Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Marker
  • 9.2.2. By Application
  • 9.2.3. By Process
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Molecular Breeding Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Marker
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Process
  • 9.3.2. UAE Molecular Breeding Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Marker
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Process
  • 9.3.3. South Africa Molecular Breeding Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Marker
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Process

10. South America Molecular Breeding Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Marker
  • 10.2.2. By Application
  • 10.2.3. By Process
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Molecular Breeding Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Marker
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Process
  • 10.3.2. Colombia Molecular Breeding Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Marker
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Process
  • 10.3.3. Argentina Molecular Breeding Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Marker
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Process

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Molecular Breeding Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Eurofins Scientific SE
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. GC Group
• 15.3. Illumina Inc.
• 15.4. SGS SA
• 15.5. Thermo-Fisher Scientific Inc.
• 15.6. Intertek Group plc
• 15.7. LemnaTec GmbH
• 15.8. Charles River Laboratories International Inc.
• 15.9. Bayer AG
• 15.10. Slipstream Solutions

16. Strategic Recommendations

17. About Us & Disclaimer